Japanese Infrastructure Stock News

Shiseido Company recently introduced the Vital Perfection Intensive SculptDefine Serum, a lifting skincare product that applies proprietary D-AminoLift Complex™, Watercress Extract and 4MSK to target facial sagging, firmness, dark spots and dullness, with clinical data indicating visible improvements across multiple wrinkle and tone concerns within one week. The new serum strengthens Shiseido's higher end skincare lineup with a clinically supported lifting and brightening formula that can...

JAPAN POST BANK (TSE:7182) has drawn investor attention after its recent share price move, with the stock up over the past month while still showing a decline over the past week. That recent pullback sits against a much stronger backdrop, with JAPAN POST BANK showing a year-to-date share price return of 44.55% and a 1-year total shareholder return of 79.14%, which points to strong longer-term momentum despite softer short-term trading. Scan opportunities with similar momentum and financial...

AGC stock has delivered a 21.2% gain over the past year, yet current valuation work suggests the market price may still sit below what the company’s cash flows justify. Investors looking at AGC today see both its recent share performance and an intrinsic value estimate that point to further room between price and fundamentals. The 21.2% return over the last 12 months signals that the market has already rewarded AGC holders, which raises the bar for any new upside case. Future cash generation...

SB Energy’s planned IPO, backed by SoftBank Group (TSE:9984), puts a fresh spotlight on the conglomerate’s AI computing ambitions. The listing depends on future data-center projects, long-dated contracts, and execution on large infrastructure buildouts. The SoftBank Group share price has pulled back 4% over the past day to ¥6,540. That follows a sharp 17% 7 day share price return and an 18% 30 day move, with a 1 year total shareholder return of 44% and a 5 year total shareholder return above...

MediPal Holdings (TSE:7459) and partner JCR Pharmaceuticals have dosed the first patient in a global Phase I/II trial of JR-446 for mucopolysaccharidosis type IIIB. The JR-446 study targets a rare lysosomal storage disorder that currently has no approved disease modifying treatments worldwide. MediPal holds commercialization rights for JR-446 outside Japan under its collaboration with JCR Pharmaceuticals. The first patient dosing in this JR-446 trial is only one piece of what is changing for...

Activist proposals put Nichirei under a brighter spotlight Oasis Management’s new campaign at Nichirei (TSE:2871) has pushed the frozen foods and logistics group into focus for investors watching potential shifts in asset mix, governance, and capital returns. Recent trading has reflected that spotlight on Nichirei, with the share price at ¥2,171 after a 0.9% 1-day move and a 7-day share price return of 3.0%. The 16.4% year to date share price gain and 29.2% 1-year total shareholder return...

Seiko Group (TSE:8050) has quietly drawn attention after recent share performance data showed a mixed pattern. The stock declined over the past week and month, yet posted strong gains across the past 3 months and year. For context, Seiko Group’s share price is now at ¥8,920, after falling 4.6% in the last session and 20.6% over the past month. The shares still show strong underlying momentum, with a 27.4% 3 month share price return and a 1 year total shareholder return of 169.5%, supported by...

Glory’s Velera partnership and why it matters for investors Glory (TSE:6457) just announced a partnership with Velera that integrates Co-op Shared Branch Express into its TellerConcierge kiosk, giving credit union visitors self-service access to seven common shared branch transactions. Glory’s share price closed at ¥4,297 on the latest trading day, with a 1 day share price return of 1.42% following the Velera announcement, although the 7 day and 30 day share price returns declined 6.81% and...

On 10 September 2026, Oasis Management Company Ltd. disclosed that it had begun formal talks with SMS Co., Ltd. on portfolio moves, AI and data use, pricing, and board composition, while flagging potential proposals on major asset transactions, leadership changes, business transfers, delisting, and share acquisitions. The breadth of topics Oasis has put on the table points to pressure on SMS’s core business mix and governance structure, which could influence how the group allocates capital...

Nippon Shokubai (TSE:4114) has drawn fresh attention after a recent price move that left the share price at ¥2,507, prompting investors to reassess the chemical producer’s value and recent return profile. Recent trading tells a mixed story for Nippon Shokubai. The share price has eased over the past week and month, with the 7 day share price return down 3.05% and the 30 day share price return down 5.70%. However, momentum over a longer stretch is stronger, with a 90 day share price return of...

Astellas Pharma announced an agreement with the U.S. government to lower Medicaid drug prices and donate 25 kg of tacrolimus API to the U.S. Strategic Active Pharmaceutical Ingredients Reserve, aligning future U.S. pricing with levels in other developed markets. The move ties Astellas Pharma’s U.S. pricing more closely to international benchmarks. This change could alter its long term balance between drug affordability, margins, and reinvestment capacity in research and development. We will...

Tulip Licensing Ltd has launched the Tulip Imaging patent licensing program, giving licensees access to more than 125,000 Canon, Sony, Huawei and OPPO patents covering digital imaging and information processing technologies. Canon’s participation in Tulip Imaging points to a heavier focus on monetizing its imaging intellectual property, potentially widening revenue sources beyond hardware and traditional equipment sales. This article examines how Canon’s investment narrative is affected by...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Koito Manufacturing stock has delivered a solid 20.3% gain over the past year, yet its valuation picture is split, with an intrinsic value estimate pointing to upside while market multiples flag a richer price tag. For anyone tracking the shares today, Koito Manufacturing screens as undervalued on a Discounted Cash Flow, but broader checks suggest the stock is not a straightforward bargain. The 20.3% return over the past year signals that the recent share move has already priced in a...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

JACCS (TSE:8584) has moved into focus after its board approved a wide credit screening reorganization, including consolidating operations to seven hubs and introducing workforce rationalization at four regional locations. For context, JACCS shares trade at ¥3,730 after a 1-day share price return of 1.08%. However, the year-to-date share price return is down 13.66%, and the 1-year total shareholder return has declined 10.93%. This hints that enthusiasm around the restructuring and recent...

GMO Payment Gateway (TSE:3769) has drawn fresh attention after recent trading left the share price at ¥8,293, with the stock down over the past week and month but roughly flat across the past 3 months. For context, GMO Payment Gateway’s share price has dropped 18.5% over the past month and 12.6% year to date. However, the 1 year total shareholder return of 2.0% suggests dividends and past price gains have partly cushioned recent losing momentum. Compare GMO Payment Gateway’s recent pullback...

Pan Pacific International Holdings brings a mixed valuation picture to the table right now, with an intrinsic value estimate that points to a premium to the current share price while market based multiples flag the stock as potentially cheap. The share price has also pulled back in recent months, which puts more weight on which of these signals investors trust most. Over the past 5 years, Pan Pacific International Holdings has returned about 87.4%, which puts the recent share price weakness...

Sony Group (TSE:6758) has drawn fresh attention after unveiling its first fisheye zoom lens for the E-mount system, the FE 8-14mm f/3.5 G, aimed at video, photo and VR creators. The new lens arrives after a weak run for the Sony Group share price. The 7 day share price return has declined 6.51% and the year to date share price return is down 10.96%. However, the 3 year total shareholder return is 50.22%, which points to long term holders still sitting on sizable gains while short term...

Yamaha’s new drum hardware launch and why it matters for the stock Yamaha (TSE:7951) has rolled out a next generation drum hardware lineup, adding three new products and refreshing multiple stands and cymbal accessories. Investors watching the musical instruments segment now have a fresh product catalyst to assess. Despite the drum hardware launch grabbing attention, Yamaha’s share price has been under pressure in the short term, with a 7-day share price return of down 7.28% and a 30-day...

Recent trading in Sumitomo Mitsui Trust Group (TSE:8309) has drawn attention after a one day gain of 0.4%, set against a past week decline of 2.1% and a strong rise year to date. That short-term pullback sits against a much stronger backdrop for Sumitomo Mitsui Trust Group, with a 30-day share price return of 3.46%, a 90-day gain of 18.37% and a powerful 1-year total shareholder return of 71.09% that reflects shifting expectations around its prospects and risk profile. Scan opportunities...

DeNA (TSE:2432) is back in focus after Utopai Studios revealed a collaboration that brings its PAI cinematic AI system into DeNA’s experimental animation workflows, testing AI-assisted visual development and production iteration. Despite the AI collaboration grabbing headlines, DeNA’s recent 7 day share price return is down 4.92%, and the 90 day share price return is down 6.72%. However, total shareholder return over the past 3 years is 71.05% and 5 year total shareholder return is 34.49%,...

Fujitsu (TSE:6702) just renewed its partnership with Palantir, deepening work on AI platforms, while also unveiling a working diamond spin quantum computing prototype that can plug into its Hybrid Quantum Computing Platform. Against that backdrop, Fujitsu’s share price has softened in the very short term, with the stock down 1.16% over the past day and 4.00% over the last week, even though the 90 day share price return of 14.85% and three year total shareholder return of 107.52% point to...

Kawasaki Kisen Kaisha (TSE:9107) has drawn fresh attention after a recent move in its share price, with the stock closing at ¥3,395. Investors are reassessing performance metrics and return history in light of this shift. That recent move sits on top of a strong run, with Kawasaki Kisen Kaisha posting a 30 day share price return of 18.25% and a year to date share price gain of 55.91%, while the 5 year total shareholder return of 474.36% points to momentum that has built over several years...